This topic contains a solution. Click here to go to the answer

Author Question: Sovereign Immunity. Nuovo Pignone, Inc, is an Italian company that designs and man-ufactures turbine ... (Read 28 times)

RRMR

  • Hero Member
  • *****
  • Posts: 557
Sovereign Immunity. Nuovo Pignone, Inc, is an Italian company that designs and man-ufactures turbine systems. Nuovo sold a turbine system to Cabinda Gulf Oil Co (CABGOC). The system was manufactured, tested, and inspected in Italy, then sent to Louisiana for mount-ing on a platform by CABGOC's contractor. Nuovo sent a representative to consult on the mounting. The platform went to a CABGOC site off the coast of West Africa. Marcus Pere, an instrument technician at the site, was killed when a turbine within the system exploded. Pere's widow filed a suit in a federal district court against Nuovo and others. Nuovo claimed sovereign immunity on the ground that its majority shareholder at the time of the explosion was Ente Nazionale Idrocaburi, which was created by the government of Italy to lead its oil and gas exploration and development. Is Nuovo exempt from suit under the doctrine of sovereign immunity? Is it subject to suit under the commercial activity exception? Why or why not?

Question 2

Which of the four general factors which bear upon whether a master-servant relationship exists is determinative:
 a. selection and engagement of the servant b. payment of compensation
  c. power of dismissal d. power of control
  e. all of the other specific choices are determinative



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Awesome

  • Sr. Member
  • ****
  • Posts: 280
Answer to Question 1

Sovereign immunity
The court held that because Ente Nazionale Idrocaburi was an agent or instrumentality of the Italian government, Nuovo was a foreign state entitled to sovereign immunityunless an ex-ception applied. The court concluded that an exception did apply: Nuovo was not entitled to immunity because of its commercial activity in the United States. On Nuovo's appeal, the U.S. Court of Appeals for the Ninth Circuit reversed the second part of the lower court's decision, holding that Nuovo was not subject to suit under the commercial activity exception. The appel-late court explained that for this exception to apply, Pere's widow's suit must be based upon . . . an act performed within the United States in connection with a commercial activity of the foreign state elsewhere. The commercial activity . . . elsewhere was the design and manu-facture of turbine systems. There was not, however, an act performed in the United States in connection with that activity. The act in the United StatesNuovo's sending a representative to Louisiana to consult on the final assemblywas not sufficiently in connection with the de-sign and manufacture of the system to subject Nuovo to liability. The court reasoned that the mounting of the system by CABGOC's contractor on its platform was not part of the design or manufacture of the system, which occurred in Italy. Thus, there was no connection between Nuovo's sending a representative to Louisiana and Pere's widow's suit.

Answer to Question 2

d




RRMR

  • Member
  • Posts: 557
Reply 2 on: Jun 24, 2018
Thanks for the timely response, appreciate it


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library